BRUNETTO , Maurizia Rossana

Last name: BRUNETTO

First name: Maurizia Rossana

2020 (v1)

Publication

Metadata-only

Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis

Sangiovanni, Angelo Alimenti, Eleonora Gattai, Riccardo

No description

Uploaded on: April 14, 2023
2022 (v1)

Publication

Metadata-only

Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

Pelizzaro, Filippo Haxhi, Selion Penzo, Barbara

No description

Uploaded on: April 14, 2023
2022 (v1)

Publication

Metadata-only

Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Stefanini, Benedetta Bucci, Laura Santi, Valentina

No description

Uploaded on: February 11, 2024
2021 (v1)

Publication

Metadata-only

Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

Marasco, Giovanni Colecchia, Antonio Bacchi Reggiani, Maria Letizia

Sorafenib is the gold standard therapy for the advanced hepatocellular carcinoma (HCC). No scoring/staging is universally accepted to predict the survival of these patients.

Uploaded on: April 14, 2023
2023 (v1)

Publication

Metadata-only

Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

Reggidori, Nicola Bucci, Laura Santi, Valentina

Background & aims: Alcohol abuse and metabolic disorders are leading causes of hepatocellular carcinoma (HCC) worldwide. Alcohol-related aetiology is associated with a worse prognosis compared with viral agents, because of the lower percentage of patients diagnosed with HCC under routine surveillance and a higher burden of comorbidity in...

Uploaded on: February 13, 2024
2017 (v1)

Publication

Metadata-only

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Kondili, Loreta A Gaeta, Giovanni Battista Brunetto, Maurizia Rossana

Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure.

Uploaded on: April 14, 2023
August 2019 (v1)

Journal article

Metadata-only

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

Raimondo, Giovanni Locarnini, Stephen Pollicino, Teresa

International audience

Uploaded on: December 4, 2022

BRUNETTO , Maurizia Rossana

Recent uploads